Clinical Trial Update: RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide

View source ↗

Summary

RegisterNET is a registry for neuroendocrine tumors in the USA and worldwide. It is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Tumor
• Neuroendocrine Carcinoma
• Neuroendocrine Tumor

Snippet

Sponsor: Wren Laboratories LLC | Conditions: Neuroendocrine Tumor, Carcinoid | Status: ENROLLING_BY_INVITATION